2.88
price down icon0.69%   -0.02
after-market アフターアワーズ: 2.83 -0.05 -1.74%
loading
前日終値:
$2.90
開ける:
$2.85
24時間の取引高:
268.31K
Relative Volume:
0.44
時価総額:
$43.26M
収益:
-
当期純損益:
$-64.47M
株価収益率:
-0.4656
EPS:
-6.1852
ネットキャッシュフロー:
$-52.33M
1週間 パフォーマンス:
-8.57%
1か月 パフォーマンス:
-49.83%
6か月 パフォーマンス:
-52.48%
1年 パフォーマンス:
-83.39%
1日の値動き範囲:
Value
$2.81
$2.93
1週間の範囲:
Value
$2.81
$3.25
52週間の値動き範囲:
Value
$2.265
$26.05

Jasper Therapeutics Inc Stock (JSPR) Company Profile

Name
名前
Jasper Therapeutics Inc
Name
セクター
Healthcare (1164)
Name
電話
(650) 549-1400
Name
住所
2200 BRIDGE PKWY SUITE #102, REDWOOD CITY
Name
職員
64
Name
Twitter
Name
次回の収益日
2024-11-07
Name
最新のSEC提出書
Name
JSPR's Discussions on Twitter

JSPR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
JSPR
Jasper Therapeutics Inc
2.88 43.56M 0 -64.47M -52.33M -6.1852
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.13 117.32B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.87 58.89B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
401.80 51.14B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
673.80 41.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.01 32.59B 3.81B -644.79M -669.77M -6.24

Jasper Therapeutics Inc Stock (JSPR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-08 ダウングレード BMO Capital Markets Outperform → Market Perform
2025-07-08 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2025-07-07 ダウングレード Cantor Fitzgerald Overweight → Neutral
2025-07-07 ダウングレード William Blair Outperform → Mkt Perform
2025-02-13 開始されました UBS Buy
2024-12-06 開始されました BMO Capital Markets Outperform
2024-09-09 開始されました JMP Securities Mkt Outperform
2024-07-08 開始されました BTIG Research Buy
2024-06-27 開始されました Stifel Buy
2024-05-06 開始されました H.C. Wainwright Buy
2024-04-03 開始されました Evercore ISI Outperform
2024-03-28 開始されました RBC Capital Mkts Outperform
2024-03-18 開始されました TD Cowen Outperform
2023-08-11 開始されました CapitalOne Overweight
2022-02-28 開始されました Cantor Fitzgerald Overweight
2021-11-08 開始されました Credit Suisse Outperform
2021-10-21 開始されました William Blair Outperform
2021-10-20 開始されました BMO Capital Markets Outperform
2021-10-13 開始されました Oppenheimer Outperform
すべてを表示

Jasper Therapeutics Inc (JSPR) 最新ニュース

pulisher
Aug 01, 2025

What is the risk reward ratio of investing in Jasper Therapeutics Inc. Equity Warrant stockBest Dividend Data Feed Backed By Experts - jammulinksnews.com

Aug 01, 2025
pulisher
Aug 01, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc. - GlobeNewswire Inc.

Aug 01, 2025
pulisher
Jul 31, 2025

What catalysts could drive Jasper Therapeutics Inc. stock higher in 2025Stock Market Recommendation With Low Risk - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 31, 2025

What are the technical indicators suggesting about Jasper Therapeutics Inc. Equity WarrantStock Strategy Review For Beginners - jammulinksnews.com

Jul 31, 2025
pulisher
Jul 28, 2025

Press Release: Jasper Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - 富途牛牛

Jul 28, 2025
pulisher
Jul 28, 2025

What is the dividend policy of Jasper Therapeutics Inc. Equity Warrant stockGet ahead with breakthrough trading ideas - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is Jasper Therapeutics Inc. company’s growth strategyPre Market Picks With High Returns - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Should I hold or sell Jasper Therapeutics Inc. Equity Warrant stock in 2025Top Growth Alerts With Proven Results - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Jasper Therapeutics Inc. stock price move sharplyPost Market Picks With Low Risk - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Jasper Therapeutics Inc. Equity Warrant generate profit in a changing economySmart Portfolio Signals To Watch Now - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Is Jasper Therapeutics Inc. stock overvalued or undervaluedAchieve rapid portfolio growth with expert help - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What is the risk reward ratio of investing in Jasper Therapeutics Inc. stockCapitalize on market trends early - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What are Jasper Therapeutics Inc. Equity Warrant company’s key revenue driversRapidly expanding wealth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Should I hold or sell Jasper Therapeutics Inc. stock in 2025Free Stock Selection - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Why is Jasper Therapeutics Inc. Equity Warrant stock attracting strong analyst attentionMaximize portfolio value with smart investment plans - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How does Jasper Therapeutics Inc. compare to its industry peersFree Stock Forecasts For 2025 - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

What institutional investors are buying Jasper Therapeutics Inc. stockBuild wealth faster with consistent investment plans - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

When is Jasper Therapeutics Inc. stock expected to show significant growthFree Market Dynamics Reports - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

Does Jasper Therapeutics Inc. Equity Warrant stock perform well during market downturnsMassive wealth growth - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 28, 2025

How strong is Jasper Therapeutics Inc. Equity Warrant company’s balance sheetGain access to exclusive stock analysis - jammulinksnews.com

Jul 28, 2025
pulisher
Jul 27, 2025

Is Jasper Therapeutics Inc. Equity Warrant stock overvalued or undervaluedFree Stock Market Return Analysis - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What is the dividend policy of Jasper Therapeutics Inc. stockMaximize gains with professional stock picks - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Jasper Therapeutics, Inc.JSPR - WV News

Jul 27, 2025
pulisher
Jul 27, 2025

Today is July 27 2025 - AInvest

Jul 27, 2025
pulisher
Jul 25, 2025

Jasper Therapeutics Inc. Equity Warrant Stock Analysis and ForecastBreakneck growth rates - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

When is the best time to buy Jasper Therapeutics Inc. Equity Warrant stockConsistently high yield - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Jasper Therapeutics Inc. Equity Warrant stockFree Stock Market Forecast Reports - Autocar Professional

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Jasper Therapeutics Inc. stock priceFree Daily Trading Room Entry - Autocar Professional

Jul 24, 2025
pulisher
Jul 23, 2025

Is Jasper Therapeutics Inc. a good long term investmentPhenomenal capital appreciation - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Is Jasper Therapeutics Inc. Equity Warrant a good long term investmentFree Stock Market Return Analysis - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

Jasper Therapeutics, Inc. (NASDAQ:JSPR) Receives $29.75 Average Target Price from Analysts - Defense World

Jul 23, 2025
pulisher
Jul 23, 2025

Jasper Therapeutics Inc. Stock Analysis and ForecastSkyrocketing profit margins - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

What drives Jasper Therapeutics Inc. Equity Warrant stock priceFree Market Volatility Navigation Tips - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Jasper Therapeutics Inc. stockMarket-beating performance - jammulinksnews.com

Jul 22, 2025

Jasper Therapeutics Inc (JSPR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$75.59
price up icon 0.93%
$37.11
price up icon 0.84%
$108.69
price up icon 1.31%
$27.07
price up icon 2.65%
$107.34
price down icon 0.15%
biotechnology ONC
$299.01
price down icon 0.70%
大文字化:     |  ボリューム (24 時間):